Corvus Pharmaceuticals, Inc. (CRVS) Earnings Call Transcripts
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (CRVS) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NASDAQ and is based in US. EarningsCalls.dev maintains a full-text archive of its earnings call transcripts — 21 calls on record spanning March 5, 2020 to November 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics. The latest calls are free to read; the full history is available through our REST API.
Earnings Call History
EarningsCalls.dev has 21 Corvus Pharmaceuticals, Inc. earnings call transcripts on record, spanning March 5, 2020 to November 5, 2026. Based on this history, Corvus Pharmaceuticals, Inc. reports semi-annually. The most recent call on file is dated November 5, 2026. The full list is below — each row opens the transcript.
- Ticker
- CRVS
- Exchange
- NASDAQ
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 21
- First call
- March 5, 2020
- Most recent
- November 5, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Q3 FY2026 | Nov 5, 2026 | Read transcript → |
| Q2 FY2026 | Aug 6, 2026 | Read transcript → |
| Q4 FY2025 | Mar 12, 2026 | Read transcript → |
| Q3 FY2025 | Nov 4, 2025 | Read transcript → |
| Q2 FY2025 | Aug 7, 2025 | Read transcript → |
| Q1 FY2025 | May 8, 2025 | Read transcript → |
| Q4 FY2024 | Mar 25, 2025 | Read transcript → |
| Q3 FY2024 | Nov 12, 2024 | Read transcript → |
| Q2 FY2024 | Aug 6, 2024 | Read transcript → |
| Q1 FY2024 | May 6, 2024 | Read transcript → |
| Q4 FY2023 | Mar 19, 2024 | Read transcript → |
| Q3 FY2023 | Nov 7, 2023 | Read transcript → |
| Q2 FY2023 | Aug 8, 2023 | Read transcript → |
| Q1 FY2023 | May 8, 2023 | Read transcript → |
| Q4 FY2022 | Mar 28, 2023 | Read transcript → |
| Q3 FY2022 | Nov 3, 2022 | Read transcript → |
| Q2 FY2022 | Aug 8, 2022 | Read transcript → |
| Q4 FY2021 | Mar 10, 2022 | Read transcript → |
| Q2 FY2020 | Jul 30, 2020 | Read transcript → |
| Q1 FY2020 | Apr 30, 2020 | Read transcript → |
| Q4 FY2019 | Mar 5, 2020 | Read transcript → |